ema glp-1 vision loss recommendation ophthalmology november 2025 Novel drugs approved by the EMA, the FDA and the MHRA in 2024: A year in review - Topouzis - 2025 What ODs Need to Know

Learn differences in safety, effectiveness, regulation, cost, and what patients should consider.

We tested Gimme Care ourselves and graded it on safety, pricing, and real results

Virta has been prescribing GLP-1s for diabetes for nearly a decade

Prospective ultrasound studies show a higher prevalence of residual gastric content in GLP-1 RA users, particularly during dose escalation or when GI symptoms are present

Glucagon-like peptide-1 (GLP-1) is a member of the proglucagon incretin family implicated in the control of appetite and satiety

Dual-pathway GLP-1/GIP weight-loss injection with B6 support, provider-guided and delivered to your door